Plantas medicinales de interés en el tratamiento de úlceras y heridas

  1. José Ramón Vallejo Villalobos
  2. María Consuelo Carrasco Ramos
  3. José Antonio González González
  4. María Eugenia Reinares Rueda
  5. Marta López Herranz
  6. Salvador Postigo Mota
Revista:
Revista ROL de enfermería

ISSN: 0210-5020

Año de publicación: 2021

Título del ejemplar: Úlceras, heridas y otras lesiones cutáneas

Volumen: 44

Número: 10

Páginas: 61-73

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Revista ROL de enfermería

Resumen

Phytotherapy is a discipline which rigorously studies the treatment of diseases through the use of medicinal plants or their by-products. Based on this discipline and considering the importance of treating wounds and ulcers, the purpose of our propaedeutic study is to contribute to the development of competencies in the management of medicinal plants in the healthcare’s field. Therefore, our aims are the following ones: (1) to select the most important vulnerary species from a propaedeutic and transdisciplinary vision; (2) to provide a practical comparative overview of the selected species; (3) to consider and value the cultural importance of plants which still are recollected in the country; (4) to select a traditional plant in order to be used by healthcare personnel and (5) describe its scientific evidence, pharmacological action, use and instructions for use. After a comprehensive search in the main databases and academic search engines with information of portals and guides of recognized prestige, the selected species are presented in two blocks. The former is a synthesis of the interesting commercial plants according to the purpose and aims described: the Balsam of Peru, the Shepherd’s purse, the Calendula or Pot-Marigold, the Oak, the Sweetbriar rose and the Dragon´s blood according to their pharmacological action. In the second block a descriptive analysis of the St. John’s Wort (Hypericum perforatum) is carried out due to its cultural importance as a wound healing plant in the rural communities of a big part of Spain.

Referencias bibliográficas

  • Libster MM. A history of shaker nurse-herbalists, health reform, and the American Botanical Medical movement (1830-1860). J Holist Nurs. 2009 Dec;27(4):222-31. doi: 10.1177/0898010109342890.
  • Zahourek RP. What is Holistic Nursing Research? Is it Different? Beginnings. 2006; 26(5): 4-6.
  • Borges AM, Ceolin T, Barbieri RL, Heck RM. La inserción de las plantas medicinales en la práctica de enfermería: un creciente desafío. Enferm glob. [online] 2010; 18.
  • Vallejo JR, Peral D. Medicina alternativa y sida: hacia una comunicación más eficaz sobre las plantas medicinales. Med Clin (Barc). 2012 Feb 18;138(3):110-1. Spanish. doi: 10.1016/j.medcli.2011.07.004.
  • Ernst W. Medical plurality, medical pluralism and plural medicine. A critical reappraisal of recent scholarship. In Jütte R. (ed.). Medical pluralism. Past–present–future (pp. 11-23). Stuttgart, Germany: Franz Steiner; 2013.
  • Penkala-Gawęcka D, Rajtar M. Introduction to the special issue ‘medical pluralism and beyond’. Anthropol Med. 2016 Aug;23(2):129-34. doi: 10.1080/13648470.2016.1180584.
  • Perdiguero E. Comprender el pluralismo médico. Investig Cienc. 2019; 514: 54-55.
  • Laar A, Amoah Ampah E, Fernandez Y, Senyo Amevinya G, Nortey P, Benyah F, Akamah J, Ambenne M, Lamptey P, Free C, Legido-Quigley H, Perel P. ‘What the herbal medicine can do for me in a week, the orthodox does in a year’: Perceived efficacy of local alternative therapies influences medication adherence in patients with atherosclerotic cardiovascular disease. Health Expect. 2021 Apr;24(2):444-455. doi: 10.1111/hex.13185.
  • Castillo E, Martínez I (eds.). Manual de Fitoterapia. 2ª ed. Barcelona: Elsevier; 2015.
  • Edwards SE, Rocha IC, Williamson EM, Heinrich M (eds). Phytopharmacy: An Evidence-Based Guide to Herbal Medicinal Products. Wiley-Blackwell; 2015.
  • Vanaclocha B, Cañigueral S. (eds). Fitoterapia, Vademécum de Prescripción. 5ª ed. Barcelona: Elsevier; 2019.
  • Creus J A. Fitoterapia: la elección basada en la ciencia y la tradición. Revista ROL de Enf. 2005; 28 (3): 19-22.
  • Gao PF, Watanabe K. Introduction of the World Health Organization project of the International Classification of Traditional Medicine. Zhong Xi Yi Jie He Xue Bao. 2011 Nov;9(11):1161-4. doi: 10.3736/jcim20111101.
  • Morris W, Gomes S, Allen M. International classification of traditional medicine. Glob Adv Health Med. 2012 Sep;1(4):38-41. doi: 10.7453/gahmj.2012.1.4.005.
  • Bailey D. Stockley’s Herbal Medicines Interactions. Br J Clin Pharmacol. 2011 Jan;71(1):143. doi: 10.1111/j.1365-2125.2010.03800. x.
  • Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond). 2013 Feb;13(1):7-12. doi: 10.7861/clinmedicine.13-1-7.
  • Awortwe C, Makiwane M, Reuter H, Muller C, Louw J, Rosenkranz B. Critical evaluation of causality assessment of herb-drug interactions in patients. Br J Clin Pharmacol. 2018 Apr;84(4):679-693. doi: 10.1111/bcp.13490.
  • Farrington R, Musgrave IF, Byard RW. Evidence for the efficacy and safety of herbal weight loss preparations. J Integr Med. 2019 Mar;17(2):87-92. doi: 10.1016/j.joim.2019.01.009.
  • Babos MB, Heinan M, Redmond L, Moiz F, Souza-Peres JV, Samuels V, Masimukku T, Hamilton D, Khalid M, Herscu P. Herb-Drug Interactions: Worlds Intersect with the Patient at the Center. Medicines (Basel). 2021 Aug 5;8(8):44. doi: 10.3390/medicines8080044.
  • Bernstein N, Akram M, Yaniv-Bachrach Z, Daniyal M. Is it safe to consume traditional medicinal plants during pregnancy? Phytother Res. 2021 Apr;35(4):1908-1924. doi: 10.1002/ptr.6935.
  • Carrasco MC, Vallejo JR, Pardo-de-Santayana M, Peral D, Martín MA, Altimiras J. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytother Res. 2009 Dec;23(12):1795-6. doi: 10.1002/ptr.2847.
  • Vallejo JR, Peral D, Gemio P, Carrasco MC, Heinrich M, Pardo-de-Santayana M. Atractylis gummifera and Centaurea ornata in the Province of Badajoz (Extremadura, Spain)-Ethnopharmacological importance and toxicological risk. J Ethnopharmacol. 2009 Nov 12;126(2):366-70. doi: 10.1016/j.jep.2009.08.036.
  • Alostad AH, Steinke DT, Schafheutle EI. Herbal Medicine Classification: Policy Recommendations. Front Med (Lausanne). 2020 Feb 11; 7:31. doi: 10.3389/fmed.2020.00031.
  • Xiong Y, Gao M, van Duijn B, Choi H, van Horssen F, Wang M. International policies and challenges on the legalization of traditional medicine/herbal medicines in the fight against COVID-19. Pharmacol Res. 2021 Apr; 166:105472. doi: 10.1016/j.phrs.2021.105472.
  • Lee DYW, Li QY, Liu J, Efferth T. Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis. Phytomedicine. 2021 Jan; 80:153337. doi: 10.1016/j.phymed.2020.153337.
  • Wu XV, Dong Y, Chi Y, Yu M, Wang W. Traditional Chinese Medicine as a complementary therapy in combat with COVID-19-A review of evidence-based research and clinical practice. J Adv Nurs. 2021 Apr;77(4):1635-1644. doi: 10.1111/jan.14673.
  • Scopus [Internet] Elsevier. 2004- [citado 8 de marzo de 2021]. Disponible en: https://www.scopus.com/
  • BIREME [Internet] São Paulo (Brasil): [Biblioteca Regional de Medicina] Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde Departamento de Evidência e Inteligência para Ação em Saúde. Organización Panamericana de la Salud y Organización Mundial de la Salud (OPS/OMS). 2009 – [citado 15 de marzo de 2021]. Disponible en: https://www.paho.org/en/bireme. Consulta: https://bvsalud.org/
  • LILACS [Internet], São Paulo (Brasil): BIREME – OPS – OMS Centro Latinoamericano y del Caribe de Información en Ciencias de la Salud Departamento de Evidencia e Inteligencia para la Acción en Salud; 1982- [citado 7 de marzo de 2021]. Disponible en: https://lilacs.bvsalud.org/es/
  • EMBASE [Internet] Elsevier. 2010- [citado 10 de marzo de 2021]. Disponible en: https://www.elsevier.com/solutions/embase-biomedical-research
  • PubMed [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 1996- [citado 10 de marzo de 2021]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/
  • Google Scholar [Internet]. Mountain View (US) Google, LLC. 2004- [citado 2 de abril de 2021]. Disponible en: https://scholar.google.com/
  • SciELO – Scientific Electronic Library Online [Internet]. São Paulo/SP – Brasil: Publishing platform, FAPESP—BIREME; 1991- [citado 3 de abril de 2021]. Disponible en: https://scielo.org/
  • MeSH Browser [Internet]. Los Ángeles: National Library of Medicine (US). 2019 – [citado 9 de marzo de 2021]. Disponible en: http://www.nlm.nih.gov/mesh/MBrowser.html
  • Portalfarma.com [Internet]. Consejo General de Colegios Oficiales de Farmacéuticos [18 abril 2021]. Disponible en https://www.portalfarma.com/. Herramientas informáticas BOT PLUS app y BOT PLUS web https://www.portalfarma.com/inicio/botplus20/Paginas/Bot-PLUS-2-0.aspx
  • Fitoterapia.net [Internet]. Valencia: CITA Publicaciones y Documentación SL. [actualizada 2 septiembre 2021]. Plantas medicinales [pantalla de inicio]. Dirección electrónica. Disponible en: https://www.fitoterapia.net/
  • Pardo de Santayana M, Morales R, Aceituno L, Molina M (eds.). Inventario Español de los Conocimientos Tradicionales relativos a la Biodiversidad. Fase 1. Introducción, metodología y fichas. Madrid: Ministerio de Agricultura, Alimentación y Medio Ambiente; 2014. Disponible: https://www.miteco.gob.es/es/biodiversidad/temas/inventarios-nacionales/inventario-espanol-de-los-conocimientos-tradicionales/inventario_esp_conocimientos_tradicionales.aspx
  • Pardo de Santayana M, Morales R, Tardío J, Aceituno-Mata L, Molina M (eds). Inventario Español de los Conocimientos Tradicionales relativos a la Biodiversidad. Segunda fase (3 volúmenes). Madrid: Ministerio para la Transición Ecológica; 2018. Disponible en: https://www.miteco.gob.es/es/biodiversidad/temas/inventarios-nacionales/inventario-espanol-de-los-conocimientos-tradicionales/inventario_esp_conocimientos_tradicionales.aspx
  • Tardío J, Pardo de Santayana M, Morales R, Molina M, Aceituno L (eds). Inventario Español de los Conocimientos Tradicionales relativos a la Biodiversidad Agrícola. Volumen 1. Madrid: Ministerio de Agricultura, Pesca y Alimentación; 2018. Disponible: https://www.mapa.gob.es/es/agricultura/temas/medios-de-produccion/iect_cultivadas_altaweb1_tcm30-500251.pdf
  • Jiménez Sesma ML, Simón-Melchor L, Solano-Castán J, Simón-Melchor A. Evidencia científica sobre el Aloe vera en las úlceras por presión como estrategia de seguridad. Med Nat. 2015; 9 (2) (2015): 5-11.
  • EMA – HMPC. European Union herbal monograph on Aloe barbadensis Mill. and on Aloe (various species, mainly Aloe ferox Mill. and its hybrids), folii succus siccatus. London: EMA. Doc. Ref.: EMA/HMPC/625788/2015. Adopted: 22/11/2016.
  • EMA – HMPC. Final Assessment report on herbal monograph on Aloe barbadensis Mill. and on Aloe (various species, mainly Aloe ferox Mill. and its hybrids), folii succus siccatus. London: EMA. Doc. Ref.: EMA/HMPC/759585/2015. Adopted: 22/11/2016.
  • EMA – HMPC. List of references supporting the assessment of Aloe barbadensis Mill. and on Aloe (various species, mainly Aloe ferox Mill. and its hybrids), folii succus siccatus. London: EMA. Doc. Ref.: EMEA/HMPC/759584/2015. Adopted: 22/11/2016.
  • EMA. Medicine (Herbal) [Internet]. Amsterdam: European Medicines Agency’s [citado 18 de abril 2021]. Disponible en www.ema.europa.eu/en/medicines/herbal
  • [45] EMA. The Committee on Herbal Medicinal Products (HMPC) [Internet]. Amsterdam: European Medicines Agency’s [citado 18 de abril 2021]. Disponible: https://www.ema.europa.eu/en/committees/committee-herbal-medicinal-products-hmpc
  • Blumenthal, Mark, Alicia Goldberg, and Josef Brinckmann. Herbal medicine. Expanded commission E monographs. Newton: Integrative Medicine Communications; 2000.
  • European Scientific Cooperative on Phytotherapy. ESCOP monographs, The Scientific Foundation for Herbal Medicinal Products. Online series. Calendulae flos (Calendula flower). Exeter: ESCOP; 2019.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Final assessment report on Calendula officinalis L., flos – Revision 1. London: EMA. Doc. Ref.: EMA/HMPC/603409/2017. Adopted: 14/6/2018.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Final European Union herbal monograph on Calendula officinalis L., flos – Revision 1. London: EMA. Doc. Ref.: EMA/HMPC/437450/2017. Adopted: 22/6/2018.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Assessment report on Myroxylon balsamum (L.) Harms var. pereirae (Royle) Harms, balsamum. London: EMA. Doc. Ref.: EMA/HMPC/712648/2014. Adopted: 24/11/2015.
  • Lock O, Pérez E, Villar M, Flores D, Rojas R. Bioactive Compounds from Plants Used in Peruvian Traditional Medicine. Nat Prod Commun. 2016 Mar;11(3):315-37.
  • Kaur S, Vasar M. Contact allergy to the ingredients of moisturizers in a boy with atopic dermatitis. Contact Dermatitis. 2017 Mar;76(3):180-181. doi: 10.1111/cod.12660.
  • Nanda A, Wasan A. Allergic contact dermatitis to balsam of Peru. Ann Allergy Asthma Immunol. 2016 Aug;117(2):208-9. doi: 10.1016/j.anai.2016.06.012.
  • Lubbes S, Rustemeyer T, Sillevis Smitt JH, Schuttelaar ML, Middelkamp-Hup MA. Contact sensitization in Dutch children and adolescents with and without atopic dermatitis - a retrospective analysis. Contact Dermatitis. 2017 Mar;76(3):151-159. doi: 10.1111/cod.12711.
  • De Groot AC. Myroxylon pereirae resin (balsam of Peru) – A critical review of the literature and assessment of the significance of positive patch test reactions and the usefulness of restrictive diets. Contact Dermatitis. 2019 Jun;80(6):335-353. doi: 10.1111/cod.13263.
  • Uter W, Werfel T, Lepoittevin JP, White IR. Contact Allergy-Emerging Allergens and Public Health Impact. Int J Environ Res Public Health. 2020 Apr 1;17(7):2404. doi: 10.3390/ijerph17072404.
  • Schottenhammer A. «Peruvian balsam»: an example of transoceanic transfer of medicinal knowledge. J Ethnobiol Ethnomed. 2020 Nov 9;16(1):69. doi: 10.1186/s13002-020-00407-y.
  • Riesmeier M, Mattonai M, Wong SS, Veall MA, Betts J, Johnston M, Ribechini E, Devièse T. Molecular profiling of Peru Balsam reveals active ingredients responsible for its pharmaceutical properties. Nat Prod Res. 2020 Apr 21:1-6. doi: 10.1080/14786419.2020.1753056.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Capsella bursa-pastoris (L.) Medikus, herba. London: EMA, Doc. Ref. EMA/HMPC/262766/2010. Adopted 21/12/2011
  • Park CJ, Park CB, Hong SS, Lee HS, Lee SY, Kim SC. Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd’s purse, Capsella bursa-pastoris. Plant Mol Biol. 2000 Sep;44(2):187-97. doi: 10.1023/a:1006431320677.
  • Ghalandari S, Kariman N, Sheikhan Z, Mojab F, Mirzaei M, Shahrahmani H. Effect of Hydroalcoholic Extract of Capsella bursa pastoris on Early Postpartum Hemorrhage: A Clinical Trial Study. J Altern Complement Med. 2017 Oct;23(10):794-799. doi: 10.1089/acm.2017.0095.
  • Naafe M, Kariman N, Keshavarz Z, Khademi N, Mojab F, Mohammadbeigi A. Effect of Hydroalcoholic Extracts of Capsella Bursa-Pastoris on Heavy Menstrual Bleeding: A Randomized Clinical Trial. J Altern Complement Med. 2018 Jul;24(7):694-700. doi: 10.1089/acm.2017.0267.
  • Givol O, Kornhaber R, Visentin D, Cleary M, Haik J, Harats M. A systematic review of Calendula officinalis extract for wound healing. Wound Repair Regen. 2019 Sep;27(5):548-561. doi: 10.1111/wrr.12737.
  • Chanaj-Kaczmarek J, Paczkowska M, Osmałek T, Kaproń B, Plech T, Szymanowska D, Karaźniewicz-Łada M, Kobus-Cisowska J, Cielecka-Piontek J. Hydrogel Delivery System Containing Calendulae flos Lyophilized Extract with Chitosan as a Supporting Strategy for Wound Healing Applications. Pharmaceutics. 2020 Jul 7;12(7):634. doi: 10.3390/pharmaceutics12070634.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Quercus robur L., Quercus petraea. (Matt.) Liebl., Quercus pubescens Willd., cortex. London: EMA. Doc. Ref.: EMA/HMPC/3203/2009. Adopted: 25/11/2010.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Assessment report on Quercus robur L., Quercus petraea (Matt.) Liebl., Quercus pubescens Willd., cortex. London: EMA. Doc. Ref.: EMA/HMPC/3206/2009. Adopted: 25/11/2010.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Addendum to Assessment report on Quercus robur L., Quercus petraea (Matt.) Liebl., Quercus pubescens Willd., cortex. Amsterdam: EMA. Doc. Ref.: EMA/HMPC/645526/2018. Adopted: 25/11/2019.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). List of references supporting the assessment of Quercus robur L., Quercus petraea (Matt.) Liebl., Quercus pubescens Willd., cortex. London: EMA. Doc. Ref.: EMA/HMPC/3205/2009. Adopted: 25/11/2010.
  • Vanaclocha B, Risco E, Cañigueral S. Interacciones entre preparados vegetales y fármacos de síntesis: revisión de las monografías de la EMA y ESCOP. Rev de Fitoter. 2014;14(1):5-36.
  • Vanaclocha B, Cañigueral S. Tabla de interacciones entre preparados vegetales y fármacos de síntesis, basada en las monografías de la EMA y ESCOP. Disponible en: www.fitoterapia.net. Actualizada: 24/7/2021.
  • Gao J, Yang X, Yin W, Li M. Gallnuts: A Potential Treasure in Anticancer Drug Discovery. Evid Based Complement Alternat Med. 2018 Mar 29; 2018:4930371. doi: 10.1155/2018/4930371.
  • Patel S, Rauf A, Khan H. The relevance of folkloric usage of plant galls as medicines: Finding the scientific rationale. Biomed Pharmacother. 2018 Jan; 97:240-247. doi: 10.1016/j.biopha.2017.10.111.
  • Taib M, Rezzak Y, Bouyazza L, Lyoussi B. Medicinal Uses, Phytochemistry, and Pharmacological Activities of Quercus Species. Evid Based Complement Alternat Med. 2020 Jul 31; 2020:1920683. doi: 10.1155/2020/1920683.
  • Abdel Hay R, Shalaby K, Zaher H, Hafez V, Chi CC, Dimitri S, Nabhan AF, Layton AM. Interventions for acne scars. Cochrane Database Syst Rev. 2016 Apr 3;4(4):CD011946. doi: 10.1002/14651858.CD011946.pub2.
  • Botta i Orfila A, Vila Casanovas R. Evidencias para el empleo del aceite de rosa mosqueta en heridas y cicatrices cutáneas. Rev de Fitoter 2017; 17 (2): 133-143.
  • Ochando-Ibernón G, Schneller-Pavelescu L, Silvestre-Salvador JF. Allergic contact dermatitis caused by «Rosa mosqueta» oil. Contact Dermatitis. 2018 Oct;79(4):259-260. doi: 10.1111/cod.13083.
  • Aguirre-Romero AB, Galeano-Valle F, Conde-Montero E, Velázquez-Tarjuelo D, de-la-Cueva-Dobao P. Efficacy and safety of a rosehip seed oil extract in the prevention and treatment of skin lesions in the hands of patients with type 1 diabetes mellitus caused by finger prick blood glucose monitoring; a randomized, open-label, controlled clinical trial. Endocrinol Diabetes Nutr (Engl Ed). 2020 Mar;67(3):186-193. doi: 10.1016/j.endinu.2019.04.008.
  • Risco E, Ghia F, Vila R, Iglesias J, Alvarez E, Cañigueral S. Immunomodulatory activity and chemical characterisation of Sangre de drago (dragon’s blood) from Croton lechleri. Planta Med. 2003 Sep;69(9):785-94. doi: 10.1055/s-2003-43208.
  • Risco E, Vila R, Henriques A, Cañigueral S. Bases quimicas y farmacológicas de la utilización de la Sangre de drago. Rev de Fitoter. 2005; 5 (2): 101-114.
  • Pona A, Cline A, Kolli SS, Taylor SL, Feldman SR. Review of future insights of Dragon’s Blood in dermatology. Dermatol Ther. 2019 Mar;32(2): e12786. doi: 10.1111/dth.12786.
  • Las Heras K, Igartua M, Santos-Vizcaino E, Hernandez RM. Chronic wounds: Current status, available strategies and emerging therapeutic solutions. J Control Release. 2020 Dec 10; 328:532-550. doi: 10.1016/j.jconrel.2020.09.039.
  • Zhang A, Liu Y, Qin D, Sun M, Wang T, Chen X. Research status of self-healing hydrogel for wound management: A review. Int J Biol Macromol. 2020 Dec 1; 164:2108-2123. doi: 10.1016/j.ijbiomac.2020.08.109.
  • Rubio Guerrero E, Amor Morales Á, Delgado Sánchez S, Muñoz Centeno LM. Hypericum perforatum. In: Pardo-de-Santayana M, Morales R, Tardío j, Aceituno-Mata L y Molina M, eds. Inventario Español de los Conocimientos Tradicionales relativos a la Biodiversidad. Fase II (3). Madrid: Ministerio de Agricultura, Alimentación y Medio Ambiente; 2018. p. 145-154.
  • Apaydin EA, Maher AR, Shanman R, Booth MS, Miles JN, Sorbero ME, Hempel S. A systematic review of St. John’s wort for major depressive disorder. Syst Ver. 2016; 5 (1):148.
  • Oliveira AI, Pinho C, Sarmento B, Dias AC. Neuroprotective activity of Hypericum perforatum and its major components. Front Plant Sci. 2016; 7: 1004.
  • Seifritz E, Hatzinger M, Holsboer-Trachsler E. Efficacy of Hypericum extract WS 5570 compared with paroxetine in patients with a moderate major depressive episode – a subgroup analysis. Int J Psychiatry Clin Pract. 2016; 20 (3): 126-32.
  • Yücel, A., Kan, Y., Yesilada, E., & Akın, O. Effect of St. John’s wort (Hypericum perforatum) oily extract for the care and treatment of pressure sores; a case report. J Ethnopharmacol. 2017; 196, 236-241.
  • Ng QX, Venkatanarayanan N, Ho CY. Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis. J Affect Disord. 2017; 210: 211-221.
  • Matić IZ, Ergün S, Đorđić Crnogorac M, Misir S, Aliyazicioğlu Y, Damjanović A, Džudžević-Čančar H, Stanojković T, Konanç K, Petrović N. Cytotoxic activities of Hypericum perforatum L. extracts against 2D and 3D cancer cell models. Cytotechnology. 2021 Jun;73(3):373-389. doi: 10.1007/s10616-021-00464-5.
  • Ramos Núñez ÁF. Hypericum L., en Castroviejo S., Aedo C., Cirujano S., Laínz M., Montserrat P., Morales R., Muñoz Garmendia F., Navarro C., Paiva J., Soriano C., (eds.), Flora iberica, 3. – Madrid: Real Jardín Botánico, CSIC; 2006. p. 157-185
  • ANTHOS. Sistema de información sobre plantas en España [Internet]. Madrid: Fundación Biodiversidad y el CSIC [citado 20 de diciembre de 2019). Disponible en: http://www.anthos.es/
  • Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ. Understanding drug interactions with St John’s wort (Hypericum perforatum L.): impact of hyperforin content. J Pharm Pharmacol 2018; 7.
  • Peryea T, Southall N, Miller M, Katzel D, Anderson N, Neyra J, Stemann S, Nguyễn ÐT, Amugoda D, Newatia A, Ghazzaoui R, Johanson E, Diederik H, Callahan L, Switzer F. Global Substance Registration System: consistent scientific descriptions for substances related to health. Nucleic Acids Res. 2021 Jan 8;49(D1): D1179-D1185. doi: 10.1093/nar/gkaa962.
  • Vallejo Villalobos JR, Peral Pacheco D, Carrasco Ramos MC, Plaza Gragera J. Remedios basados en plantas medicinales usadas en la Medicina Popular guadianera: “El aceite de árnica”. Rev Estud Extremeños 2007; 63(1): 307-317.
  • European Scientific Cooperative on Phytotherapy. ESCOP monographs, The Scientific Foundation for Herbal Medicinal Products. Online series. Hyperci herba (St. John’s Wort). Exeter: ESCOP; 2018.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Hypericum perforatum L., herba (well-established medicinal use). London: EMA. Doc. Ref.: EMA/HMPC/101304/2008. Adopted: 12/11/2009.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Hypericum perforatum L., herba (traditional use) Draft. London: EMA. Doc. Ref.: EMA/188804/2017. Adopted: 30/01/2018.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Hypericum perforatum L., herba (well stablished and traditional use) 2nd Draft – Revision 1. London: EMA. Doc. Ref.: EMA/HMPC/7695/2021. Published: 16/04/21.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Assessment report on Hypericum perforatum L., herba. 2nd Draft – Revision 1. Amsterdam: EMA. Doc. Ref.: EMA/HMPC/244315/2016. Published: 16/04/21.
  • European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). List of references supporting the assessment of Hypericum perforatum L., herba. 2nd Draft – Revision 1. Amsterdam: EMA. Doc. Ref.: EMA/HMPC/45511/2017. Published: 16/04/21.
  • Istikoglou CI, Mavreas V, Geroulanos G. History and therapeutic properties of Hypericum perforatum from antiquity until today. Psychiatriki. 2010 Oct-Dec;21(4):332-8.
  • Butterweck V. (2009) St. John’s Wort: quality issues and active compounds. In: Cooper R, Kronenberg F. (Eds.) Botanical Medicine: from Bench to Bedside. Mary Ann Liebert Inc, USA.
  • Schepetkin IA, Özek G, Özek T, Kirpotina LN, Khlebnikov AI, Quinn MT. Chemical Composition and Immunomodulatory Activity of Hypericum perforatum Essential Oils. Biomolecules. 2020 Jun 17;10(6):916. doi: 10.3390/biom10060916.
  • Vuko E, Dunkić V, Ruščić M, Nazlić M, Mandić N, Soldo B, Šprung M, Fredotović Ž. Chemical Composition and New Biological Activities of Essential Oil and Hydrosol of Hypericum perforatum L. ssp. veronense (Schrank) H. Lindb. Plants (Basel). 2021 May 19;10(5):1014. doi: 10.3390/plants10051014.
  • Avila C, Whitten D, Evans S. The safety of St John’s wort (Hypericum perforatum) in pregnancy and lactation: A systematic review of rodent studies. Phytother Res 2018;32(8):1488-1500.
Fuente de los datos: Dialnet